Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A review of global cancer burden: trends, challenges, strategies, and a role for surgeons.

Literature DB >> 22926725

A review of global cancer burden: trends, challenges, strategies, and a role for surgeons.

Chandrakanth Are¹, Shireen Rajaram, Madhuri Are, Hemanth Raj, Benjamin O Anderson, Ramesh Chaluvarya Swamy, Manavalan Vijayakumar, Tianqiang Song, Manoj Pandey, James A Edney, Eduardo L Cazap.

Abstract

Cancer is one of the leading causes of death worldwide. The global cancer burden (GCB) is expected to rise significantly and will disproportionately affect the less developed world (LDW). The aim of this review is to analyze the trends in GCB and describe the types, estimates, and causes of new cancer cases. The challenges and strategies associated with tackling this rising GCB are described in which surgeons can play a vital role.

Entities: Disease

Mesh：

Year: 2012 PMID： 22926725 DOI： 10.1002/jso.23248

Source DB: PubMed Journal: J Surg Oncol ISSN： 0022-4790 Impact factor: 3.454

Keyword Cloud
Cited

37 in total

1. Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer.

Authors: Leila Sisic; Daniel Vallböhmer; Nikolas H Stoecklein; Susanne Blank; Thomas Schmidt; Christiane Driemel; Birte Möhlendick; Wolfram T Knoefel; Margarete Odenthal; Katja Ott
Journal: Oncol Lett Date: 2015-06-09 Impact factor: 2.967

2. In vivo evaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpoints.

Authors: Srivalleesha Mallidi; Zhiming Mai; Imran Rizvi; Joshua Hempstead; Stephen Arnason; Jonathan Celli; Tayyaba Hasan
Journal: J Biomed Opt Date: 2015-04 Impact factor: 3.170

3. A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancer.

Authors: Hui Yu; Jian Zhang; Xianghua Wu; Zhiguo Luo; Huijie Wang; Si Sun; Wei Peng; Jie Qiao; Yu Feng; Jialei Wang; Jianhua Chang
Journal: Cancer Biol Ther Date: 2014-04-22 Impact factor: 4.742

4. Interaction Between Gastric Carcinoma Cells and Neural Cells Promotes Perineural Invasion by a Pathway Involving VCAM1.

Authors: Qijun Xia; Qing-Ran Bai; Maosheng Dong; Xicai Sun; Haihong Zhang; Jianxin Cui; Hongqin Xi; Xiao-Ling Hu; Qin Shen; Lin Chen
Journal: Dig Dis Sci Date: 2015-06-25 Impact factor: 3.199

5. Does the existence of HCMV components predict poor prognosis in glioma?

Authors: Daling Ding; Sheng Han; Zixun Wang; Zongze Guo; Anhua Wu
Journal: J Neurooncol Date: 2014-01-07 Impact factor: 4.130

6. Role of RNA-interference-induced zinc finger protein 139 suppression in gastric cancer cell sensitivity to chemotherapeutic agents.

Authors: Ying-Jie Hao; Yong Li; Li-Qiao Fan; Qun Zhao; Bi-Bo Tan; Zhi-Kai Jiao; Xue-Feng Zhao; Zhi-Dong Zhang; Dong Wang
Journal: Oncol Lett Date: 2015-06-24 Impact factor: 2.967

A review of global cancer burden: trends, challenges, strategies, and a role for surgeons.

1. Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer.

2. In vivo evaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpoints.

3. A phase II randomized trial evaluating gefitinib intercalated with pemetrexed/platinum chemotherapy or pemetrexed/platinum chemotherapy alone in unselected patients with advanced non-squamous non-small cell lung cancer.

4. Interaction Between Gastric Carcinoma Cells and Neural Cells Promotes Perineural Invasion by a Pathway Involving VCAM1.

5. Does the existence of HCMV components predict poor prognosis in glioma?

6. Role of RNA-interference-induced zinc finger protein 139 suppression in gastric cancer cell sensitivity to chemotherapeutic agents.

7. CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.

8. Ranking composite Cancer Burden Indices for geographic regions: point and interval estimates.

Review 9. The role of engineering approaches in analysing cancer invasion and metastasis.

10. The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis.